CEO of Amphistar, start-up established in 2021, spin-off company from Ghent University and the Bio Base Europe Pilot Plant (BBEPP). AmphiStar is revolutionizing the surfactant market by introducing microbial biosurfactants derived from locally sourced waste- and side-products from the agri-food industry, such as supermarket food waste. These innovative and circular biosurfactants do not compete with food production nor do they directly impact land use. AmphiStar offers a comprehensive portfolio of biobased, biologically produced and biocompatible glycolipids such as sophorolipids to the Home & Personal Care industry, seeking genuinely sustainable, high-performing, and affordable alternatives. These biosurfactants come in various forms and purities, serving as perfect drop-in replacements for existing formulations while significantly reducing the carbon footprint of finished products.With its technology platform, AmphiStar can also develop new biosurfactants with enhanced functionalities.

Entrepreneurial initiative, complementary to my corporate assignmentsWe have created the company Altarence in 2014 as a mean to finance, promote, develop, support spinoffs & startups in the circular economy, new technologies or disruptive business models. Focus domains are CCUS, chemistry, renewable energies, water preservation and re-use, among others. We partner with universities to identify and invest at very early stage in promising science-based projects with purpose. We support the founding teams with our methodology, business and industry knowledge, company management skills, coaching and care. We also invest as Business Angels on more mature projects with CSR goals and impact on society. Since June 2022, we have also been members of Paris Business Angels (PBA) and Referent for a PBA investment in Carbon Waters. Do not hesitate to reach out to us! Projects: Carbon Waters Investor in 2022InOpSys Co-Founding shareholder in 2015Soléo-Ecosolutions Shareholder - Seed Investor - 2018 Energo Shareholder - Early Coach & Partner - 2016 to 2022

CEO of Blue Industry & Science Blue Industry & Science provides solutions for monitoring continuously multiple gases at very low concentrations (ppb/ppm traces) up to % levels. Our technology is based on a breakthrough BTL (Broadly Tunable Laser) optical laser measurement, issued from aerospace research, covering a very large broad band. This technology has unique performances compared to “classical” gas monitoring technologies such as TDL lasers, NDIR, GC, FTIR, PID, UV …The main applications are: • Continuous 24h/24 monitoring of regulated environmental pollutants emissions (eg. chimney) for compliance purposes. We can measure precisely and simultaneously multiple complex molecules• Mapping of pollutant emissions in workshops, labs, plants….to measure exposition levels of a few ppbs for HSE (Health Safety Environment) improvements • Provide quality assurance trackers or process monitoring related to gas emissions directly in your processes under vacuum or at atmospheric pressure

Lead Global Business Unit Performance Polyamides and deliver P&L/cash targets, while preparing a successful transition towards BASF ownership.1 Billion€ revenues and ~230M€ EBITDA, 7 production sites in LATAM, Asia and Europe , 1300+ employees.Record high EBITDA in 2019 in a context of soft demand in AutomotiveSuccessful closing of transaction on Jan 31st 2020 with activity taken over by BASF Strong focus on communication, remobilization of the GBU teams and management of change

- Heading PMO (Project Management Office) of Solvay “Oxygen O2” global transformation project kicked-off in 2017 by CEO to develop a higher performing, more agile and customer centric organization. Coordination of diagnostic, solution design and implementation preparation of breakthrough modifications in organization, governance and culture. - Design and lead 2017 restructuring project targeting reduction of SG&A and R&I expenses of Solvay Novecare GBU following Oil & Gas business downturn.- Heading corporate IMO (Integration Management Office) of Cytec (2B$ revenues US company; main activities in composites materials for aeronautics & mining; acquired for 5,5B$) developing master planning, supervising consulting teams to ensure identification, implementation and tracking of cost and business synergies.

Lead the Asia-Pacific Novecare business, support functions and industrial teams, ensuring delivery of EBITDA and cash targets. Chairman of the board & director of 9 legal entities in China, India and South-East Asia.650M€ revenues, 1750 employees and 11 plants (India, China, SEA) producing specialty & commodity surfactants, polymers, monomers, phosphorus derivatives and amines.

- Lead Amines global business unit (200M€ revenues, 25 employees) - Head newly created global “Strategic Product Line Management” function, developing WW strategies and footprint optimization to ensure competitiveness of Novecare GBU (1,7B€ revenues) key technologies

- Design Novecare’s strategy in Asia-Pacific to ensure breakthrough growth. - Lead business due diligence resulting in acquisition of Chinese surfactant & amines producer Feixiang in May 2010 for 500M$ and filing of MOFCOM antitrust filing. Organized and led the full Integration of Feixiang within Novecare GBU.

Responsible of the Asia-Pacific Home & Personal Care market (100M€ revenues, 20 employees). Unilever GKAM.

Responsible of Home & Personal Care market in Europe, Middle East, Africa (65M€ revenues, 7 employees). L’Oreal GKAM.